🧬 Parag Shah - Part 1 | Rethinking Biotech Startup Funding | Building Smarter Capital Strategies | Risk, Reward & Leadership in Investing


Episode Artwork
1.0x
0% played 00:00 00:00
Feb 03 2025 47 mins   2
🧬 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success.

🔬 Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸

🔗 Get your unique referral link here: refer.excedr.com/ZTHETY

Part 1 of 2: Our guest today is Parag Shah, CEO and Founding Managing Director of K2 HealthVentures. K2 HealthVentures is an alternative investment firm that provides flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. Committed to making a broader impact, K2 also donates a percentage of its profits to support underserved areas in healthcare.

Before founding K2, Parag was Senior Managing Director & Group Head of the Life Sciences practice at Hercules Capital, where he led the fund’s public offering and managed over $2 billion in investments. His deep expertise in life science and healthcare financing was further shaped through key leadership roles at Comerica, Imperial Bank, and BankBoston.Parag’s academic background includes a Masters in Environmental Policy & Planning and a Bachelors in Molecular Biology from MIT, where he conducted research at the Whitehead Institute. 

With 25+ years of experience at the intersection of science and finance, Parag brings invaluable insights for first-time founders, investors, scientists, and industry leaders navigating the complexities of biotech funding.

In this episode, you'll hear about:

  • How Parag’s NYC upbringing shaped his leadership and risk-taking mindset
  • His transition from molecular biology to finance and investing
  • Key lessons from his early career in credit and venture lending
  • How he helped shape biotech venture credit and redefine startup financing
  • When to use debt vs. equity in life sciences fundraising

If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening!


Find Our Guest, Parag Shah, at these links: 

Find Our Host, Jon Chee, at these links: 

Excedr Socials & Website

Enriched Notes:

Topics Mentioned:
Hercules Capital: https://www.htgc.com/
BankBoston (now part of Bank of America): https://en.wikipedia.org/wiki/BankBoston
Imperial Bank (acquired by Comerica):  https://www.comerica.com/
Risk-Taking & Leadership in Startups:

People Mentioned:

Timestamps:
00:00 Intro
02:59 Parag’s background and early career in finance
06:24 Growing up in NYC and how his parents influenced his mindset
09:42 The impact of education and key mentors in shaping his path
15:11 Transitioning from science to finance, why he left the lab
19:56 Lessons from Bank Boston and entering the world of credit investing
24:32 Moving to Argentina and unexpected entry into banking
29:56 Joining Imperial Bank and the challenges of building biotech venture credit
36:37 Understanding risk-taking and decision-making in biotech financing
42:52 When startups should use debt vs. equity and how venture debt fits into biotech funding
46:02 Outro
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so